0001883067-23-000001.txt : 20230712 0001883067-23-000001.hdr.sgml : 20230712 20230712115738 ACCESSION NUMBER: 0001883067-23-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230712 DATE AS OF CHANGE: 20230712 EFFECTIVENESS DATE: 20230712 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Affect Therapeutics, Inc. CENTRAL INDEX KEY: 0001883067 IRS NUMBER: 852224169 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-486606 FILM NUMBER: 231083596 BUSINESS ADDRESS: STREET 1: 520 BROADWAY, 4TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10012 BUSINESS PHONE: 000-000-0000 MAIL ADDRESS: STREET 1: 520 BROADWAY, 4TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10012 D 1 primary_doc.xml X0708 D LIVE 0001883067 Affect Therapeutics, Inc. 1640 Boro Place 4th Floor McLean VA VIRGINIA 22102 9295522849 DELAWARE None None Corporation true 2020 Kristin Muhlner C/o Affect Therapeutics, Inc. 1640 Boro Place, 4th Floor McLean VA VIRGINIA 22102 Executive Officer Director Jeff DeFlavio C/o Affect Therapeutics, Inc. 1640 Boro Place, 4th Floor McLean VA VIRGINIA 22102 Director Kevin Ryan C/o Affect Therapeutics, Inc. 1640 Boro Place, 4th Floor McLean VA VIRGINIA 22102 Director Jeff Rinehart C/o Affect Therapeutics, Inc. 1640 Boro Place, 4th Floor McLean VA VIRGINIA 22102 Director Stuart Peterson C/o Affect Therapeutics, Inc. 1640 Boro Place, 4th Floor McLean VA VIRGINIA 22102 Director Other Health Care Decline to Disclose 06b false 2022-12-16 false true false 0 18073362 18073362 0 The total amount sold includes convertible notes and the securities issuable hereto. false 9 0 0 0 false Affect Therapeutics, Inc. /s/Kristin Muhlner Kristin Muhlner Chief Executive Officer 2023-07-12